Abstract
444P Efficacy and safety of sintilimab in combination with anlotinib plus metronomic chemotherapy in advanced triple-negative breast cancer (SPACE): Preliminary results of a single-arm, multicenter phase II trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have